PubMed Health⌕ Search

PubMed · 16395484

[Fibrinolytic therapy].

Abstract

Fibrinolytic therapy still is a keystone in the therapeutic approach of acute occlusion in different vascular regions. However, before starting fibrinolytic therapy an evidence-based risk assessment is necessary. This article presents the most common fibrinolytic agents as well as evidences and recommendations for fibrinolytic therapy of different vascular regions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Beyer, S Schellong. 2005. [Fibrinolytic therapy].. https://pubmed.ncbi.nlm.nih.gov/16395484/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Medical and surgical treatment of venous malformations].

Treatment of venous malformations (VM) is difficult as these lesions are ill defined and can infiltrate tissues. Moreover, no specific treatment related to their etiopathogenesis exists. Currently, VM can be treated conservatively or medically and, more aggressively with either sclerotherapy, or surgical resection. A multidisciplinary approach is needed to obtain the best result with minimal complications. Surgical resection, complete or partial, plays an important role in the treatment of symptomatic VM. In case of extensive VM, all techniques of plastic surgery are indicated.

Fibrinolytic Agents↗